A detailed history of Covington Investment Advisors Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Covington Investment Advisors Inc. holds 20,629 shares of LLY stock, worth $16.4 Million. This represents 2.75% of its overall portfolio holdings.

Number of Shares
20,629
Previous 20,528 0.49%
Holding current value
$16.4 Million
Previous $18.6 Million 1.67%
% of portfolio
2.75%
Previous 2.98%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $77,986 - $96,962
101 Added 0.49%
20,629 $18.3 Million
Q2 2024

Nov 13, 2024

SELL
$724.87 - $909.04 $326,916 - $409,977
-451 Reduced 2.15%
20,519 $18.6 Million
Q2 2024

Aug 16, 2024

SELL
$724.87 - $909.04 $320,392 - $401,795
-442 Reduced 2.11%
20,528 $18.6 Million
Q1 2024

Nov 13, 2024

SELL
$592.2 - $792.28 $577,395 - $772,473
-975 Reduced 4.44%
20,970 $16.3 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $577,395 - $772,473
-975 Reduced 4.44%
20,970 $16.3 Million
Q4 2023

Nov 13, 2024

BUY
$525.19 - $619.13 $40,964 - $48,292
78 Added 0.36%
21,945 $12.8 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $40,964 - $48,292
78 Added 0.36%
21,945 $12.8 Million
Q3 2023

Nov 13, 2024

BUY
$434.7 - $599.3 $141,277 - $194,772
325 Added 1.51%
21,867 $11.7 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $141,277 - $194,772
325 Added 1.51%
21,867 $11.7 Million
Q2 2023

Nov 13, 2024

SELL
$350.74 - $468.98 $36,827 - $49,242
-105 Reduced 0.49%
21,542 $10.1 Million
Q2 2023

Aug 10, 2023

SELL
$350.74 - $468.98 $36,827 - $49,242
-105 Reduced 0.49%
21,542 $10.1 Million
Q1 2023

Nov 13, 2024

BUY
$310.63 - $364.82 $316,221 - $371,386
1,018 Added 4.93%
21,647 $7.43 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $1.54 Million - $1.81 Million
-4,950 Reduced 18.61%
21,647 $7.43 Million
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $215,438 - $251,028
670 Added 2.58%
26,597 $9.73 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $133,712 - $152,379
451 Added 1.77%
25,927 $8.38 Million
Q2 2022

Aug 10, 2022

SELL
$278.73 - $327.27 $69,682 - $81,817
-250 Reduced 0.97%
25,476 $8.26 Million
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $530,399 - $659,151
-2,260 Reduced 8.08%
25,726 $7.37 Million
Q3 2021

Nov 10, 2021

SELL
$221.6 - $272.71 $57,616 - $70,904
-260 Reduced 0.92%
27,986 $6.47 Million
Q2 2021

Aug 09, 2021

BUY
$180.55 - $233.54 $34,123 - $44,139
189 Added 0.67%
28,246 $6.48 Million
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $12,981 - $16,804
79 Added 0.28%
28,057 $5.24 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $2,739 - $3,625
21 Added 0.08%
27,978 $4.72 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $21,933 - $25,369
150 Added 0.54%
27,957 $4.14 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $6,820 - $8,209
-50 Reduced 0.18%
27,807 $4.57 Million
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $4,762 - $5,894
-40 Reduced 0.14%
27,857 $3.86 Million
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $2,669 - $2,904
-25 Reduced 0.09%
27,897 $3.12 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $70,351 - $82,118
635 Added 2.33%
27,922 $3.09 Million
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $77,917 - $91,714
700 Added 2.63%
27,287 $3.54 Million
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $72,329 - $81,031
-683 Reduced 2.5%
26,587 $3.08 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $12,449 - $15,559
-145 Reduced 0.53%
27,270 $2.93 Million
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $15,897 - $18,244
210 Added 0.77%
27,415 $2.34 Million
Q1 2018

May 10, 2018

BUY
$74.21 - $87.6 $61,965 - $73,146
835 Added 3.17%
27,205 $2.11 Million
Q4 2017

Feb 13, 2018

BUY
$81.94 - $87.89 $81,940 - $87,890
1,000 Added 3.94%
26,370 $2.23 Million
Q3 2017

Nov 02, 2017

BUY
$77.07 - $85.54 $56,646 - $62,871
735 Added 2.98%
25,370 $2.17 Million
Q1 2017

Nov 02, 2017

BUY
N/A
24,635
24,635 $2.07 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Covington Investment Advisors Inc. Portfolio

Follow Covington Investment Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Investment Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Covington Investment Advisors Inc. with notifications on news.